Diabetes and obesity and risk of pyogenic liver abscess.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 05 2023
Historique:
received: 16 12 2022
accepted: 09 05 2023
medline: 18 5 2023
pubmed: 17 5 2023
entrez: 16 5 2023
Statut: epublish

Résumé

Few literatures discussed the relationship of glycemic control and body mass index (BMI) with the risk of pyogenic liver abscess. We conducted a population-based cohort study using participants of a community-based health screening program in Taiwan from 2005 to 2008 (n = 125,865). Information on fasting plasma glucose (FPG), BMI, and other potential risk factors of liver abscess were collected at baseline. Incidence of pyogenic liver abscess was ascertained using inpatient records from the National Health Insurance database. During a median 8.6 years of followed up, 192 incident cases of pyogenic liver abscess were reported. The incidence rate of pyogenic liver abscess was 70.2 and 14.7 per 100,000 in the diabetic and non-diabetic population respectively. In multivariable Cox regression analysis, the adjusted hazard ratio (HR) was 2.18 (95% confidence interval (CI) 1.22-3.90) in patients with diabetes with good glycemic control (FPG ≤ 130 mg/dl) and 3.34 (95% CI 2.37-4.72) in those with poor glycemic control (FPG > 130 mg/dl), when compared with non-diabetics. In the dose-response analysis, the risk of liver abscess increased monotonically with increasing FPG. After adjusting for diabetes and other comorbidities, overweight (25 ≤ BMI < 30) (adjusted HR: 1.43, 95% CI 1.05-1.95) and obese (BMI ≥ 30) (adjusted HR: 1.75, 95% CI 1.09-2.81) populations had a higher risk of liver abscess when compared to people with normal weight. Diabetes, especially poorly controlled disease, and high BMI were associated with higher risk of pyogenic liver abscess. Improving glycemic control and weight reduction may reduce the risk of developing pyogenic liver abscess.

Identifiants

pubmed: 37193729
doi: 10.1038/s41598-023-34889-z
pii: 10.1038/s41598-023-34889-z
pmc: PMC10188555
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7922

Informations de copyright

© 2023. The Author(s).

Références

Lancet Diabetes Endocrinol. 2016 Feb;4(2):148-58
pubmed: 26656292
Diabetes Metab Res Rev. 2007 Jan;23(1):3-13
pubmed: 16960917
Shock. 2017 Mar;47(3):276-287
pubmed: 27787406
Am J Respir Cell Mol Biol. 2016 Aug;55(2):188-200
pubmed: 27128821
Clin Microbiol Infect. 2018 Jan;24(1):24-28
pubmed: 28232162
Infection. 2013 Jun;41(3):681-6
pubmed: 23381876
Acta Unio Int Contra Cancrum. 1953;9(3):531-41
pubmed: 13124110
J Clin Endocrinol Metab. 2006 Aug;91(8):3084-7
pubmed: 16720670
Front Immunol. 2018 Jan 30;9:74
pubmed: 29441064
Open Forum Infect Dis. 2019 Aug 16;6(10):ofz358
pubmed: 31660337
Ann Emerg Med. 2009 May;53(5):639-42
pubmed: 19135282
Open Forum Infect Dis. 2020 Oct 11;8(1):ofaa545
pubmed: 33511222
Lancet Infect Dis. 2006 Jul;6(7):438-46
pubmed: 16790384
N Engl J Med. 2016 Nov 17;375(20):1961-1971
pubmed: 27959614
Alcohol. 2017 Nov;64:23-28
pubmed: 28965652
Med J Aust. 2011 Apr 4;194(7):374
pubmed: 21470095
Clin Gastroenterol Hepatol. 2004 Nov;2(11):1032-8
pubmed: 15551257
Circ J. 2016 Dec 22;81(1):36-43
pubmed: 27928145
Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):481-6
pubmed: 21739348
Clin Infect Dis. 2007 May 1;44(9):1194-201
pubmed: 17407038
JAMA. 2017 Jan 17;317(3):280-289
pubmed: 28114552
Lancet Infect Dis. 2012 Nov;12(11):881-7
pubmed: 23099082
J Leukoc Biol. 2018 Sep;104(3):525-534
pubmed: 30066958
Am J Epidemiol. 2005 Mar 15;161(6):557-64
pubmed: 15746472
Diabetes Care. 2015 Jan;38 Suppl:S33-40
pubmed: 25537705
BMC Infect Dis. 2013 Jan 30;13:56
pubmed: 23363608
Diabetes Care. 2018 Oct;41(10):2127-2135
pubmed: 30104296
EBioMedicine. 2022 Aug;82:104154
pubmed: 35816897
Am J Epidemiol. 2016 Jun 1;183(11):1008-17
pubmed: 27188940
Spine J. 2017 Aug;17(8):1100-1105
pubmed: 28343046
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
PLoS One. 2013 Nov 06;8(11):e79961
pubmed: 24223208
Am J Epidemiol. 2002 Jan 15;155(2):176-84
pubmed: 11790682
Emerg Infect Dis. 2008 Oct;14(10):1592-600
pubmed: 18826824
Virulence. 2016 Oct 2;7(7):770-8
pubmed: 27159655
Am J Kidney Dis. 2015 Jul;66(1):60-8
pubmed: 25641062
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
J Microbiol Immunol Infect. 2016 Oct;49(5):646-653
pubmed: 25442876
J Nat Sci Biol Med. 2015 Jan-Jun;6(1):71-5
pubmed: 25810638
JAMA. 1999 Apr 7;281(13):1203-10
pubmed: 10199430
BMC Health Serv Res. 2010 Aug 04;10:225
pubmed: 20682077
Int J Obes (Lond). 2013 Mar;37(3):333-40
pubmed: 22546772
Occup Environ Med. 2016 Jan;73(1):56-61
pubmed: 26514394
Public Health Nutr. 2009 Jan;12(1):129-35
pubmed: 18410705
Am J Physiol Lung Cell Mol Physiol. 2022 Jan 1;322(1):L116-L128
pubmed: 34850640
PLoS Med. 2016 Aug 09;13(8):e1002072
pubmed: 27505150
Exp Biol Med (Maywood). 2005 Nov;230(10):757-61
pubmed: 16246903
Am J Manag Care. 2008 Jan;14(1):15-23
pubmed: 18197741
J Immunol. 2002 Apr 15;168(8):4018-24
pubmed: 11937559

Auteurs

Jiun-Ling Wang (JL)

Department of Internal Medicine, National Cheng Kung University Hospital and College of Medicine, National Cheng Kung University, Tainan, Taiwan. jiunlingwang@gmail.com.

Chun-Ru Hsu (CR)

Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan.

Chieh-Yin Wu (CY)

Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.

Hsien-Ho Lin (HH)

Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH